| pubmed-article:9114103 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9114103 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:9114103 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
| pubmed-article:9114103 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:9114103 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:9114103 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9114103 | pubmed:dateCreated | 1997-5-13 | lld:pubmed |
| pubmed-article:9114103 | pubmed:abstractText | To compare the use of ferumoxide-enhanced T1-weighted gradient-echo (GRE) MR imaging with that of spiral computed tomography during arterial portography (CTAP) and T2-weighted Turbo spin-echo (SE) MR imaging in detection of lesions and of segmental involvement in patients with liver metastases. | lld:pubmed |
| pubmed-article:9114103 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9114103 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9114103 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9114103 | pubmed:month | May | lld:pubmed |
| pubmed-article:9114103 | pubmed:issn | 0033-8419 | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:SchmitzP IPI | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:WiggersTT | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:Borel... | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:OudkerkMM | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:WielopolskiP... | lld:pubmed |
| pubmed-article:9114103 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:9114103 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9114103 | pubmed:volume | 203 | lld:pubmed |
| pubmed-article:9114103 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9114103 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9114103 | pubmed:pagination | 449-56 | lld:pubmed |
| pubmed-article:9114103 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:meshHeading | pubmed-meshheading:9114103-... | lld:pubmed |
| pubmed-article:9114103 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9114103 | pubmed:articleTitle | Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. | lld:pubmed |
| pubmed-article:9114103 | pubmed:affiliation | Department of Radiology, Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. | lld:pubmed |
| pubmed-article:9114103 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9114103 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9114103 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9114103 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9114103 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9114103 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9114103 | lld:pubmed |
